Previous close | 15.91 |
Open | 15.87 |
Bid | 11.94 x 900 |
Ask | 16.95 x 1400 |
Day's range | 15.68 - 16.56 |
52-week range | 6.28 - 21.62 |
Volume | |
Avg. volume | 215,868 |
Market cap | 333.762M |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.08 |
Earnings date | 01 May 2023 - 05 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 23.33 |
MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. “Elaine is a dynamic and purpose-driven leader with over 25 years of experience in finance, accounting,
MINNEAPOLIS, March 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences: The 33rd Oppenheimer Annual Healthcare Conference, which is being held virtually from March 13th-15th. Management will participate in a virtual fireside chat on Monday, March 13th at 12:40 p.m. Eastern
MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $13.00 per share. The gross proceeds to Tactile Medical from the offering, before deducting the underwriting disc